Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir. - Bai, Francesca; Beringheli, Tomaso; Vitaletti, Virginia; Santoro, Andrea; Molà, Francesco; Copes, Alessandro; Gemignani, Nicole; Pettenuzzo, Sofia; Castoldi, Roberto; Varisco, Benedetta; Nardo, Riccardo; Lundgren, Lorenzo Brando; et al. (Infectious Diseases & Therapy, 2024)